# Optimizing Timolol Maleate Treatment of Infantile Hemangioma by Doppler Ultrasound Examination

> **NCT03842631** · — · UNKNOWN · sponsor: **XiaoXi Lin** · enrollment: 150 (estimated)

## Conditions studied

- Infantile Hemangioma

## Interventions

- **DRUG:** Timolol Maleate 0.5% Oph Soln

## Key facts

- **NCT ID:** NCT03842631
- **Lead sponsor:** XiaoXi Lin
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02-16
- **Primary completion:** 2020-06-01
- **Final completion:** 2020-12-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2019-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03842631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03842631, "Optimizing Timolol Maleate Treatment of Infantile Hemangioma by Doppler Ultrasound Examination". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT03842631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*